A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care (NCT06538064)
A Global Real-World Study to Assess HyQvia Use and Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Switching to HyQvia
🩺 Plain-English Summary (8th-Grade Level)
The main aims of this study are to understand why adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) chose a certain treatment, why they changed to HyQvia from another therapy, how satisfied they are with HyQvia and their previous treatment, how their work productivity and activity is impacted and learn about their CIDP signs and symptoms. Other aims are to collect information on any medical problems or side effects during the treatment with HyQvia, learn how effective treatment of CIDP with HyQvia is and understand details on the use of HyQvia in standard clinical routine as well on the need for healthcare intervention (such as emergency room visits or hospital visits or stays). During the study, data will be collected from medical records already available, interviews with participants at study start and study completion and via questionnaires completed by participants. Participants will be treated as per the doctor's or the clinic's routine.
Who can join: Review the eligibility criteria below.
Location: Samir Macwan MD Inc — Rancho Mirage, California
Age range: 18 Years
🧪 Interventions in This Study
- No Intervention (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (15 Sites)
- Samir Macwan MD Inc — Rancho Mirage, California
- Neuro/Psych Sleep Clinic — San Francisco, California
- Yale School Of Medicine — New Haven, Connecticut
- Nova Clinical Research, LLC — Bradenton, Florida
- Suncoast Neuroscience Associates, Inc. — St. Petersburg, Florida
- Hawaii Pacific Neuroscience — Honolulu, Hawaii
- HSHS St. Elizabeths Hospital — O'Fallon, Illinois
- University of Kansas Medical Center Research Institute, Inc. — Kansas City, Kansas
- Wake Forest University - School of Medicine - Central — Winston-Salem, North Carolina
- Arhus Universtitetshospital — Aarhus N,
- Rigshospitalet — København Ø,
- Immanuel Klinik Rudersdorf — Rüdersdorf, Brandenburg
- Universitaetsklinikum Giessen und Marburg GmbH Standort Marburg — Marburg, Hesse
- Katholisches Klinikum Bochum gGmbH — Bochum, North Rhine-Westphalia
- Judisches Krankenhaus Berlin — Berlin,
📞 Contact the Study Coordinator
Phone: (877) 825-3327
Email: medinfoUS@takeda.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Explore by condition: All Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.